PubRank

Ryukichi Kumashiro

Author PubWeight™ 31.54‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Hepatitis C virus down-regulates insulin receptor substrates 1 and 2 through up-regulation of suppressor of cytokine signaling 3. Am J Pathol 2004 2.81
2 Significance and therapeutic potential of endothelial progenitor cell transplantation in a cirrhotic liver rat model. Gastroenterology 2007 1.22
3 Tumor necrosis factor-alpha and interferon-gamma directly impair epithelial barrier function in cultured mouse cholangiocytes. Liver Int 2003 1.17
4 Overexpression of angiopoietin-1 and angiopoietin-2 in hepatocellular carcinoma. J Hepatol 2004 1.07
5 Surveillance program for early detection of hepatocellular carcinoma in Japan: results of specialized department of liver disease. J Clin Gastroenterol 2006 1.05
6 Endothelial progenitor cell transplantation improves the survival following liver injury in mice. Gastroenterology 2006 1.02
7 Severe hepatotoxicity associated with a N-nitrosofenfluramine-containing weight-loss supplement: report of three cases. J Gastroenterol Hepatol 2004 0.97
8 Assessment of 287 Japanese cases of drug induced liver injury by the diagnostic scale of the International Consensus Meeting. Hepatol Res 2003 0.97
9 Troglitazone induces p27Kip1-associated cell-cycle arrest through down-regulating Skp2 in human hepatoma cells. Hepatology 2003 0.93
10 Late-onset ornithine transcarbamylase deficiency in male patients: prognostic factors and characteristics of plasma amino acid profile. Pediatr Int 2006 0.93
11 Hydrogen peroxide overproduction in megamitochondria of troglitazone-treated human hepatocytes. Hepatology 2003 0.90
12 Causal relationship between hepatitis C virus core and the development of type 2 diabetes mellitus in a hepatitis C virus hyperendemic area: a pilot study. Int J Mol Med 2005 0.89
13 Incidence of Sjögren's syndrome in Japanese patients with hepatitis C virus infection. J Gastroenterol Hepatol 2003 0.89
14 Predicting relapse after cessation of Lamivudine monotherapy for chronic hepatitis B virus infection. Clin Infect Dis 2004 0.89
15 A decrease in AFP level related to administration of interferon in patients with chronic hepatitis C and a high level of AFP. Dig Dis Sci 2006 0.89
16 Prophylactic lamivudine administration prevents exacerbation of liver damage in HBe antigen positive patients with hepatocellular carcinoma undergoing transhepatic arterial infusion chemotherapy. Am J Gastroenterol 2004 0.88
17 Antibody to hepatitis B core antigen is associated with the development of hepatocellular carcinoma in hepatitis C virus-infected persons: a 12-year prospective study. Int J Mol Med 2006 0.88
18 A real-time quantitative polymerase chain reaction method for hepatitis B virus in patients with chronic hepatitis B treated with lamivudine. Am J Gastroenterol 2003 0.87
19 Lamivudine treatment-related morphological changes of esophageal varices in patients with liver cirrhosis. Hepatol Res 2007 0.87
20 Investigation of associating factors in exacerbation of liver damage after chemotherapy in patients with HBV-related HCC. Hepatol Res 2003 0.86
21 Exacerbation of oral erosive lichen planus by combination of interferon and ribavirin therapy for chronic hepatitis C. Int J Mol Med 2005 0.86
22 The prognosis for life in an HCV hyperendemic area. Gastroenterology 2003 0.86
23 Value of fusing PET plus CT images in hepatocellular carcinoma and combined hepatocellular and cholangiocarcinoma patients with extrahepatic metastases: preliminary findings. Liver Int 2006 0.85
24 Extrahepatic manifestations and insulin resistance in an HCV hyperendemic area. Int J Mol Med 2005 0.85
25 Development of quantitative neuropsychological tests for diagnosis of subclinical hepatic encephalopathy in liver cirrhosis patients and establishment of diagnostic criteria-multicenter collaborative study in Japanese. Hepatol Res 2004 0.81
26 A pilot study of eicosapentaenoic acid therapy for ribavirin-related anemia in patients with chronic hepatitis C. Int J Mol Med 2003 0.81
27 Markedly prolonged jaundice from simultaneous infection with hepatitis E virus and leptospira. Kurume Med J 2003 0.81
28 Genetic heterogeneity of the precore and the core promoter region of genotype C hepatitis B virus during lamivudine therapy. J Med Virol 2004 0.81
29 Analysis of approach to therapy for chronic liver disease in an HCV hyperendemic area of Japan. Hepatol Res 2004 0.80
30 Severe alcoholic hepatitis successfully treated by leukocytapheresis: a case report. Alcohol Clin Exp Res 2003 0.79
31 A mutational shift from domain III to II in the internal ribosome entry site of hepatitis C virus after interferon-ribavirin therapy. Arch Virol 2008 0.79
32 Gene transfer of kringle 1-5 suppresses tumor development and improves prognosis of mice with hepatocellular carcinoma. Gastroenterology 2006 0.79
33 Adefovir dipivoxil as a treatment for hepatic failure caused by lamivudine-resistant HBV strains. Dig Dis Sci 2004 0.79
34 Diagnostic clues for recurrent hepatocellular carcinoma: comparison of tumour markers and imaging studies. Eur J Gastroenterol Hepatol 2003 0.78
35 Predictive factors for remission and death in 73 patients with autoimmune hepatitis in Japan. Int J Mol Med 2003 0.77
36 Abnormal accumulation in lipopolysaccharide in biliary epithelial cells of rats with self-filling blind loop. Int J Mol Med 2002 0.77
37 Wilson disease protein ATP7B is localized in the late endosomes in a polarized human hepatocyte cell line. Int J Mol Med 2003 0.76
38 Expression of uncoupling protein-2 in biliary epithelial cells in primary biliary cirrhosis. Liver 2002 0.76
39 Do the national survey results reflect the state of drug-induced liver injury in a single local city in which there is no hospital having Members of the Board of Councilors of the Japan Society of Hepatology? Results of a questionnaire survey conducted in a local city. Hepatol Res 2011 0.75
40 [Fostering future gastroenterology specialists -initiatives and challenges of medical gastroenterology-]. Nihon Shokakibyo Gakkai Zasshi 2012 0.75
41 [Hepatitis C acquired through drug abuse among young generations]. Nihon Shokakibyo Gakkai Zasshi 2002 0.75
42 Timing of interferon therapy and sources of infection in patients with acute hepatitis C. Hepatol Res 2005 0.75
43 [Disappearance of basal ganglia hyperintensity on T1-weighted MR images after obliterating portal systemic shunt in a patient with hepatic encephalopathy]. Nihon Shokakibyo Gakkai Zasshi 2002 0.75
44 Predictive factors associated with the progression to hepatic failure caused by lamivudine-resistant HBV. Dig Dis Sci 2008 0.75
45 B-Flow contrast US with Levovist in hepatic tumors: preliminary results. Kurume Med J 2003 0.75
46 [A case of drug induced liver injury related pioglitazone]. Nihon Shokakibyo Gakkai Zasshi 2003 0.75
47 [Autoimmune pancreatitis with atypical ERP image and Eosinophilia]. Nihon Naika Gakkai Zasshi 2002 0.75
48 [A periappendiceal abscess during combination interferon and ribavirin treatment for chronic hepatitis C]. Nihon Shokakibyo Gakkai Zasshi 2007 0.75
49 The importance of a prior psychiatric examination in pegylated interferon and ribavirin combination treatment for chronic hepatitis C. Kurume Med J 2012 0.75
50 Clinical course of patients with chronic hepatitis B with viral breakthrough during long-term lamivudine treatment. J Gastroenterol 2005 0.75
51 Additional benefit of lamivudine treatment as a preventive therapy for hepatic encephalopathy in patients with decompensated liver cirrhosis associated with hepatitis B. Int J Mol Med 2002 0.75
52 [Revision of the training curriculum of Japan Society of Gastroenterology: gastroenterologist's role and professionalism]. Nihon Shokakibyo Gakkai Zasshi 2013 0.75
53 [A case of mesenteric cavernous hemangioma showing interestingly image study]. Nihon Shokakibyo Gakkai Zasshi 2005 0.75
54 Light and electron microscopic analyses of immediate and late tissue damage caused by radiofrequency ablation in porcine liver. Int J Mol Med 2003 0.75
55 Successful treatment with corticosteroid and lamivudine for autoimmune hepatitis in a patient with asymptomatic HBV infection. Dig Dis Sci 2007 0.75
56 Branched-chain amino acid supplementation complements conventional treatment for spontaneous bacterial peritonitis. Dig Dis Sci 2006 0.75